Cigna Group (CI) Stock Price
Cigna Group Price
Revenue has compounded at 15.9% per year over the past 19 years to 274.95 B USD. Earnings per share have grown at 10.1% per year over the last 19 years. Cigna Group's net margin stands at 2.2%, broadly stable from 3.1% several years earlier. Cigna Group currently offers a dividend yield of about 2.19%. The payout ratio is around 27% of earnings. The dividend has grown at 24.1% per year over the past 19 years. Analysts set a median price target of 331.50 USD, implying 20.3% above the current price. Of 33 analysts, 27 rate the stock a buy — an overall Buy consensus. The stock trades about 13% above its 52-week low.
Cigna Group stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of Cigna Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Cigna Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Cigna Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | Cigna Group Price |
|---|---|
| 8/4/2026 | 275.51 USD |
| 7/31/2026 | 279.05 USD |
| 7/30/2026 | 287.66 USD |
| 7/29/2026 | 297.86 USD |
| 7/27/2026 | 291.23 USD |
| 7/23/2026 | 286.29 USD |
| 7/22/2026 | 284.85 USD |
| 7/21/2026 | 290.49 USD |
| 7/20/2026 | 283.94 USD |
| 7/17/2026 | 281.45 USD |
| 7/16/2026 | 283.82 USD |
| 7/15/2026 | 297.81 USD |
| 7/14/2026 | 303.35 USD |
| 7/13/2026 | 303.20 USD |
| 7/10/2026 | 293.46 USD |
| 7/9/2026 | 291.80 USD |
| 7/8/2026 | 285.17 USD |
| 7/7/2026 | 286.62 USD |
| 7/6/2026 | 278.69 USD |
| 7/2/2026 | 287.77 USD |
| 7/1/2026 | 277.07 USD |
| 6/30/2026 | 275.68 USD |
| 6/29/2026 | 280.82 USD |
| 6/26/2026 | 282.79 USD |
| 6/25/2026 | 281.87 USD |
| 6/24/2026 | 279.46 USD |
| 6/23/2026 | 283.08 USD |
| 6/22/2026 | 280.77 USD |
| 6/18/2026 | 281.85 USD |
| 6/17/2026 | 288.21 USD |
| 6/16/2026 | 290.83 USD |
| 6/15/2026 | 295.40 USD |
| 6/12/2026 | 298.70 USD |
| 6/11/2026 | 293.94 USD |
| 6/10/2026 | 295.55 USD |
| 6/9/2026 | 295.00 USD |
| 6/8/2026 | 289.61 USD |
| 6/5/2026 | 287.86 USD |
| 6/4/2026 | 281.58 USD |
| 6/3/2026 | 270.77 USD |
| 6/2/2026 | 274.58 USD |
| 6/1/2026 | 274.86 USD |
| 5/29/2026 | 281.95 USD |
| 5/28/2026 | 287.49 USD |
| 5/27/2026 | 285.51 USD |
| 5/26/2026 | 281.24 USD |
| 5/22/2026 | 284.24 USD |
| 5/21/2026 | 283.69 USD |
| 5/20/2026 | 287.58 USD |
| 5/19/2026 | 291.28 USD |
| 5/18/2026 | 286.69 USD |
| 5/15/2026 | 285.27 USD |
| 5/14/2026 | 294.93 USD |
| 5/13/2026 | 300.71 USD |
| 5/12/2026 | 298.49 USD |
| 5/11/2026 | 289.07 USD |
| 5/8/2026 | 288.06 USD |
| 5/7/2026 | 284.04 USD |
| 5/6/2026 | 281.98 USD |
| 5/5/2026 | 275.66 USD |
| 5/4/2026 | 279.35 USD |
| 5/1/2026 | 282.90 USD |
| 4/30/2026 | 290.58 USD |
| 4/29/2026 | 292.32 USD |
| 4/28/2026 | 284.92 USD |
| 4/27/2026 | 282.58 USD |
| 4/24/2026 | 275.64 USD |
| 4/23/2026 | 279.72 USD |
| 4/22/2026 | 274.70 USD |
| 4/21/2026 | 276.69 USD |
| 4/20/2026 | 279.92 USD |
| 4/17/2026 | 278.64 USD |
| 4/16/2026 | 276.37 USD |
| 4/15/2026 | 268.63 USD |
| 4/14/2026 | 272.60 USD |
| 4/13/2026 | 275.12 USD |
| 4/10/2026 | 271.25 USD |
| 4/9/2026 | 278.45 USD |
| 4/8/2026 | 277.56 USD |
| 4/7/2026 | 274.25 USD |
| 4/6/2026 | 276.54 USD |
| 4/2/2026 | 270.02 USD |
| 4/1/2026 | 267.32 USD |
| 3/31/2026 | 266.75 USD |
| 3/30/2026 | 258.08 USD |
| 3/27/2026 | 261.95 USD |
| 3/26/2026 | 272.08 USD |
| 3/25/2026 | 270.36 USD |
| 3/24/2026 | 265.87 USD |
| 3/23/2026 | 261.49 USD |
| 3/20/2026 | 265.04 USD |
| 3/19/2026 | 264.57 USD |
| 3/18/2026 | 264.57 USD |
| 3/17/2026 | 263.47 USD |
| 3/16/2026 | 268.35 USD |
| 3/13/2026 | 267.19 USD |
| 3/12/2026 | 265.88 USD |
| 3/11/2026 | 259.82 USD |
| 3/10/2026 | 262.44 USD |
| 3/9/2026 | 269.68 USD |
| 3/6/2026 | 272.52 USD |
| 3/5/2026 | 281.27 USD |
| 3/4/2026 | 284.74 USD |
| 3/3/2026 | 283.93 USD |
| 3/2/2026 | 290.85 USD |
| 2/27/2026 | 289.82 USD |
| 2/26/2026 | 288.82 USD |
| 2/25/2026 | 284.44 USD |
| 2/24/2026 | 281.00 USD |
| 2/23/2026 | 283.18 USD |
| 2/20/2026 | 280.31 USD |
| 2/19/2026 | 285.92 USD |
| 2/18/2026 | 290.12 USD |
| 2/17/2026 | 290.71 USD |
| 2/13/2026 | 291.44 USD |
| 2/12/2026 | 287.61 USD |
| 2/11/2026 | 294.73 USD |
| 2/10/2026 | 287.81 USD |
| 2/9/2026 | 294.40 USD |
| 2/6/2026 | 292.05 USD |
| 2/5/2026 | 280.02 USD |
| 2/4/2026 | 271.71 USD |
| 2/3/2026 | 275.07 USD |
| 2/2/2026 | 271.54 USD |
| 1/30/2026 | 274.11 USD |
| 1/29/2026 | 271.27 USD |
| 1/28/2026 | 272.38 USD |
| 1/27/2026 | 270.60 USD |
| 1/26/2026 | 280.52 USD |
| 1/23/2026 | 279.20 USD |
| 1/22/2026 | 280.41 USD |
| 1/21/2026 | 274.91 USD |
| 1/20/2026 | 270.92 USD |
| 1/16/2026 | 272.21 USD |
| 1/15/2026 | 277.94 USD |
| 1/14/2026 | 271.00 USD |
| 1/13/2026 | 271.22 USD |
| 1/12/2026 | 276.02 USD |
| 1/9/2026 | 278.71 USD |
| 1/8/2026 | 283.91 USD |
| 1/7/2026 | 279.12 USD |
| 1/6/2026 | 284.76 USD |
| 1/5/2026 | 283.97 USD |
| 1/2/2026 | 279.12 USD |
| 12/31/2025 | 275.23 USD |
| 12/30/2025 | 276.48 USD |
| 12/29/2025 | 276.27 USD |
| 12/26/2025 | 276.51 USD |
| 12/24/2025 | 274.86 USD |
| 12/23/2025 | 273.75 USD |
| 12/22/2025 | 275.60 USD |
| 12/19/2025 | 271.89 USD |
| 12/18/2025 | 274.00 USD |
| 12/17/2025 | 273.84 USD |
| 12/16/2025 | 276.11 USD |
| 12/15/2025 | 277.15 USD |
| 12/12/2025 | 274.70 USD |
| 12/11/2025 | 272.26 USD |
| 12/10/2025 | 262.60 USD |
| 12/9/2025 | 262.71 USD |
| 12/8/2025 | 263.54 USD |
| 12/5/2025 | 265.44 USD |
| 12/4/2025 | 268.42 USD |
| 12/3/2025 | 270.32 USD |
| 12/2/2025 | 274.10 USD |
| 12/1/2025 | 273.57 USD |
| 11/28/2025 | 277.28 USD |
| 11/26/2025 | 278.35 USD |
| 11/25/2025 | 278.20 USD |
| 11/24/2025 | 271.47 USD |
| 11/21/2025 | 278.09 USD |
| 11/20/2025 | 269.62 USD |
| 11/19/2025 | 271.99 USD |
| 11/18/2025 | 272.61 USD |
| 11/17/2025 | 271.33 USD |
| 11/14/2025 | 269.66 USD |
| 11/13/2025 | 270.89 USD |
| 11/12/2025 | 270.61 USD |
| 11/11/2025 | 267.52 USD |
| 11/10/2025 | 258.16 USD |
| 11/7/2025 | 264.58 USD |
| 11/6/2025 | 256.40 USD |
| 11/5/2025 | 259.58 USD |
| 11/4/2025 | 264.66 USD |
| 11/3/2025 | 256.03 USD |
| 10/31/2025 | 245.37 USD |
| 10/30/2025 | 248.78 USD |
| 10/29/2025 | 299.12 USD |
| 10/28/2025 | 309.02 USD |
| 10/27/2025 | 309.18 USD |
| 10/24/2025 | 302.17 USD |
| 10/23/2025 | 305.07 USD |
| 10/22/2025 | 307.87 USD |
| 10/21/2025 | 307.50 USD |
| 10/20/2025 | 306.84 USD |
| 10/17/2025 | 299.29 USD |
| 10/16/2025 | 291.07 USD |
| 10/15/2025 | 294.57 USD |
| 10/14/2025 | 302.13 USD |
| 10/13/2025 | 295.41 USD |
| 10/10/2025 | 300.99 USD |
| 10/9/2025 | 306.13 USD |
| 10/8/2025 | 306.76 USD |
| 10/7/2025 | 307.14 USD |
| 10/6/2025 | 305.02 USD |
| 10/3/2025 | 312.02 USD |
| 10/2/2025 | 296.98 USD |
| 10/1/2025 | 291.65 USD |
| 9/30/2025 | 288.25 USD |
| 9/29/2025 | 288.25 USD |
| 9/28/2025 | 286.64 USD |
| 9/25/2025 | 286.17 USD |
| 9/24/2025 | 284.06 USD |
| 9/23/2025 | 290.02 USD |
| 9/22/2025 | 288.62 USD |
| 9/19/2025 | 290.38 USD |
| 9/18/2025 | 293.76 USD |
| 9/17/2025 | 296.59 USD |
| 9/16/2025 | 294.21 USD |
| 9/15/2025 | 297.02 USD |
| 9/12/2025 | 302.82 USD |
| 9/11/2025 | 305.87 USD |
| 9/10/2025 | 302.44 USD |
| 9/9/2025 | 302.01 USD |
| 9/8/2025 | 300.89 USD |
| 9/5/2025 | 304.93 USD |
| 9/4/2025 | 304.03 USD |
| 9/3/2025 | 300.48 USD |
| 9/2/2025 | 300.72 USD |
| 8/29/2025 | 300.89 USD |
| 8/28/2025 | 299.00 USD |
| 8/27/2025 | 299.95 USD |
| 8/26/2025 | 300.32 USD |
| 8/25/2025 | 300.76 USD |
| 8/22/2025 | 301.93 USD |
| 8/21/2025 | 300.95 USD |
| 8/20/2025 | 304.57 USD |
| 8/19/2025 | 302.11 USD |
| 8/18/2025 | 298.32 USD |
| 8/15/2025 | 296.88 USD |
| 8/14/2025 | 290.37 USD |
| 8/13/2025 | 287.10 USD |
| 8/12/2025 | 280.47 USD |
| 8/11/2025 | 277.04 USD |
| 8/8/2025 | 274.92 USD |
| 8/7/2025 | 271.00 USD |
| 8/6/2025 | 269.96 USD |
| 8/5/2025 | 270.74 USD |
| 8/4/2025 | 266.59 USD |
Cigna Group Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
Cigna Group Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITB USD |
| EBIT MARGIN% |
| NET INCOMEB USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 37.88 | 39.84 | 41.81 | 48.65 | 153.57 | 160.40 | 174.07 | 180.52 | 195.27 | 247.12 | 274.95 | 284.84 | 297.05 | 313.44 | 320.70 | 335.88 |
| 8.48 | 5.18 | 4.94 | 16.37 | 215.65 | 4.45 | 8.52 | 3.70 | 8.17 | 26.56 | 11.26 | 3.60 | 4.29 | 5.51 | 2.32 | 4.74 |
| 32.88 | 32.70 | 33.70 | 33.56 | 16.33 | 15.09 | 13.19 | 13.02 | 12.89 | 10.51 | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 | 9.45 |
| 12.45 | 13.03 | 14.09 | 16.33 | 25.08 | 24.21 | 22.95 | 23.50 | 25.18 | 25.96 | 25.99 | 26.92 | 28.07 | 29.62 | 30.31 | 31.74 |
| 12.36 | 3.09 | 3.94 | 4.16 | 8.08 | 8.15 | 7.94 | 8.45 | 8.54 | 9.42 | 9.13 | 12.11 | 12.63 | 13.32 | 13.63 | 14.28 |
| 32.63 | 7.75 | 9.43 | 8.55 | 5.26 | 5.08 | 4.56 | 4.68 | 4.37 | 3.81 | 3.32 | 4.25 | 4.25 | 4.25 | 4.25 | 4.25 |
| 2.09 | 1.87 | 2.24 | 2.64 | 5.10 | 8.46 | 5.37 | 6.70 | 5.16 | 3.43 | 5.96 | 8.63 | 9.48 | 10.47 | 11.90 | 13.12 |
| -0.38 | -10.84 | 19.82 | 17.88 | 93.55 | 65.71 | -36.51 | 24.84 | -22.97 | -33.50 | 73.47 | 44.80 | 9.87 | 10.50 | 13.59 | 10.29 |
| 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 4.00 | 4.48 | 4.92 | 5.60 | 6.04 | 6.24 | 7.49 | 8.99 | – | – |
| – | – | – | – | – | – | 9,900.00 | 12.00 | 9.82 | 13.82 | 7.86 | 3.31 | 20.03 | 20.03 | – | – |
| 256.07 | 255.52 | 249.24 | 242.58 | 370.44 | 361.12 | 329.64 | 305.41 | 294.57 | 277.78 | 265.95 | 265.95 | 265.95 | 265.95 | 265.95 | 265.95 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales Cigna Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Cigna Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Cigna Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares Cigna Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Cigna Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
Cigna Group stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
Cigna Group Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
Cigna Group business model & stock analysis
Cigna Group SWOT Analysis
Strengths
Cigna Corp has several strengths that contribute to its success in the market:
- Strong brand reputation and recognition in the healthcare industry
- Diverse portfolio of insurance and healthcare products
- Broad network of healthcare providers and facilities
- Advanced technology platforms for efficient service delivery
Weaknesses
Despite its strengths, Cigna Corp also has some weaknesses that could hinder its performance:
- Dependence on third-party providers for certain services
- Relatively high costs for insurance coverage compared to competitors
- Complex organizational structure that may impede decision-making
- Limited presence in international markets compared to some competitors
Opportunities
There are several potential opportunities that Cigna Corp can capitalize on:
- Growing demand for healthcare services due to aging population
- Expansion into emerging markets with untapped potential
- Development of innovative healthcare technologies and solutions
- Strategic partnerships and acquisitions to enhance market position
Threats
Cigna Corp also faces certain threats that could pose challenges to its business:
- Intense competition within the healthcare and insurance industry
- Regulatory changes and uncertainty in healthcare policies
- Increasing healthcare costs and potential reimbursement cuts
- Economic downturns and their impact on consumer spending
Cigna Group Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
Cigna Group Segments
Cigna Group Revenue by Segment
3 Years
5 Years
Max
Details
Cigna Group Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
Cigna Group historical P/E ratio, EBIT multiple, and P/S ratio
Cigna Group annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
Cigna Group shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
Cigna Group stock splits
Cigna Group Dividend History
38 years of dividend payments · 5 consecutive increases
Cigna Group dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
Cigna Group dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current Cigna Group forecasts and price targets in August 2026
Analyst Price Targets 2026Cigna Group Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 7/31/2026 | Maintained | Equal Weight | 56 | |
| 7/31/2026 | Maintained | Buy | 30 | |
| 7/31/2026 | Maintained | Equal Weight | 33 | |
| 7/9/2026 | Maintained | Outperform | – | |
| 6/8/2026 | Maintained | Outperform | 31 | |
| 5/26/2026 | Downgrade | OverweightEqual Weight | 33 | |
| 5/22/2026 | Maintained | Buy | 51 | |
| 5/20/2026 | Maintained | Overweight | 60 | |
| 5/20/2026 | Downgrade | BuyHold | – | |
| 5/5/2026 | Maintained | Outperform | – |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
Cigna Group Earnings Calls
Cigna Group Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 7/30/2026 | 7.81USD | - | 72.52 BUSD | - | 2026 Q2 |
| 4/30/2026 | 7.85USD | - | 68.36 BUSD | - | 2026 Q1 |
| 2/5/2026 | 8.11USD | - | 71.93 BUSD | - | 2025 Q4 |
| 5/3/2024 | 6.54USD | - | 57.14 BUSD | - | 2024 Q1 |
| 2/1/2024 | 6.73USD | - | 50.39 BUSD | - | 2023 Q4 |
| 8/2/2023 | 6.74USD | - | 48.15 BUSD | - | 2023 Q2 |
| 5/4/2023 | 6.21USD | - | 46.78 BUSD | - | 2023 Q1 |
| 2/1/2023 | 5.03USD | - | 46.47 BUSD | - | 2022 Q4 |
| 11/3/2022 | 5.89USD | - | 45.43 BUSD | - | 2022 Q3 |
| 8/4/2022 | 5.64USD | - | 45.07 BUSD | - | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the Cigna Group stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
Cigna Group shareholder structure
| % | Name |
|---|---|
7.97907% | |
6.04554% | |
4.33699% | |
4.09408% | |
4.08017% | |
3.86885% |
Cigna Group Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
9.00% | SEC ↗ | |
7.88% | SEC ↗ | |
7.51% | SEC ↗ | |
7.40% | SEC ↗ | |
5.40% | SEC ↗ | |
5.30% | SEC ↗ | |
5.30% | SEC ↗ | |
5.08% | SEC ↗ | |
4.20% | SEC ↗ | |
4.00% | SEC ↗ |
Cigna Group Executives and Management Board
17 members · avg. age 61 · 35 % women
Mr. David Cordani (59)
Chairman of the Board, Chief Executive Officer · since 2008
23.25 M USD
Management
Mr. Brian Evanko (48)
President, Chief Operating Officer
Ms. Nicole Jones (54)
Executive Vice President, Chief Administrative Officer, General Counsel
Ms. Ann Dennison (54)
Chief Financial Officer, Executive Vice President
Dr. David Brailer (65)
Executive Vice President, Chief Health Officer and Chief Transformation Officer
Mr. Ralph Giacobbe
Investor Relations · since 2022
Board of Directors
Mr. Eric Wiseman (69)
Lead Independent Director
Ms. Kimberly Ross (60)
Independent Director
Ms. Donna Zarcone (67)
Independent Director
Mr. Eric Foss (66)
Independent Director
Maj. Gen. (Retd.) Elder Granger (71)
Independent Director
Ms. Kathleen Mazzarella (65)
Independent Director
Cigna Group Supply Chain
Cigna Group Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | Berkshire Hathaway B | 0.86 | 0.63 | 0.75 | |
| 2 | -0.28 | -0.44 | 0.72 | ||
| 3 | -0.05 | 0.37 | 0.72 | ||
| 4 | -0.35 | -0.51 | 0.71 | ||
| 5 | 0.43 | 0.35 | 0.70 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | Lakshmi Vilas Bank Limited | -0.79 | — | — | |
| 2 | -0.81 | -0.67 | — | ||
| 3 | 0.57 | 0.20 | — | ||
| 4 | -0.60 | — | — | ||
| 5 | 0.50 | -0.29 | — |
Frequently asked questions about Cigna Group
Cigna Corp operates as a global health services organization, with its primary focus on providing health insurance and related services. The company offers a range of insurance products and services, including medical, dental, behavioral health, pharmacy, and disability insurance. Cigna Corp is dedicated to improving the health, well-being, and sense of security of its customers through personalized solutions and innovative healthcare programs. By leveraging its extensive network of healthcare professionals and partnerships, the company strives to deliver affordable and quality healthcare solutions to individuals, employers, and governments worldwide.
Cigna Corp is primarily active in the healthcare and insurance industries.
The main competitors of Cigna Corp in the market are UnitedHealth Group, Anthem Inc., Aetna Inc., and Humana Inc. These companies also operate in the health insurance industry and provide similar products and services. However, Cigna Corp distinguishes itself through its focus on personalized health and well-being solutions, strong global presence, and innovative approach to healthcare delivery. With its commitment to customer-centricity and extensive network, Cigna Corp continues to compete and thrive in the highly competitive health insurance market.
Cigna Corp, founded in 1792 as Insurance Company of North America (INA), has a rich history and background. Over the years, the company has evolved and expanded its offerings to become a leading global health services organization. Cigna Corp provides a wide range of insurance services, including health, dental, disability, and life insurance, as well as pharmacy benefits management. With a commitment to improving the health and well-being of its customers, Cigna Corp has established itself as a trusted provider of comprehensive healthcare solutions. Today, it continues to innovate and adapt to meet the evolving needs of individuals and businesses worldwide.
Cigna Corp, a renowned healthcare services company, has achieved several significant milestones throughout its history. Notably, in 1982, Cigna became the first company to offer a 24-hour, toll-free 800 telephone number for customer service. In 1996, they pioneered the concept of a consumer-directed healthcare plan called Cigna Choice Fund. The company's acquisition of HealthSpring in 2012 expanded its Medicare Advantage business significantly. Furthermore, Cigna's merger with Express Scripts in 2018 solidified its position as a leading global health service company, combining pharmacy benefit management with comprehensive healthcare solutions. These milestones showcase Cigna Corp's commitment to innovation and customer-centric healthcare services.
Cigna Corp is primarily present in the United States, with its headquarters located in Bloomfield, Connecticut. It operates its health services in various states across the country, offering a wide range of healthcare and insurance products. Additionally, Cigna Corp has expanded its global presence and serves customers in several other countries and regions, including but not limited to, the United Kingdom, Canada, Mexico, Brazil, China, India, and several countries across Europe and Asia.
Cigna Corp represents values of integrity, diversity, collaboration, and innovation. The company's corporate philosophy is centered around providing quality healthcare solutions and improving the well-being of its customers. Cigna Corp is dedicated to serving its clients with empathy and compassion, ensuring access to affordable and personalized healthcare services. With a focus on delivering value and excellence, Cigna Corp constantly strives to enhance its offerings, embracing technological advancements and fostering a culture of continuous improvement. Through its commitment to customer-centricity and ethical practices, Cigna Corp aims to make a positive impact on the lives of individuals and communities worldwide.
Analysts currently set an average price target of 333.92 USD for the Cigna Group stock (median: 331.50 USD), implying +19.7 % versus the latest price. The consensus is based on 33 analyst ratings.
33 analysts currently rate the Cigna Group stock: 27 recommend buying, 6 holding and 0 selling. For 2026, analysts expect Cigna Group to generate revenue of 284.84 B USD and earnings per share of 32.44 USD.
Converted at the current exchange rate, the Cigna Group share trades at 239.34 EUR (275.51 USD).
The Cigna Group share (CI) is listed on 9 stock exchanges, including: NYSE (CI), XETRA (CGN.DE), Frankfurt (CGN.F), München (CGN.MU), Düsseldorf (CGN.DU), Hamburg (CGN.HM), London (0A77.L), SIX (Zürich) (CGN.SW).
Cigna Corp is a global company operating in the healthcare industry with its headquarters in the USA. The company operates in various sectors and offers products and services targeting different customers. The different sectors and products offered by Cigna Corp are described below. The first sector of Cigna Corp is the insurance business. This is the company's core competency. Cigna Corp offers various types of insurance, with a focus on health insurance. The company provides both private health insurance and group insurance. The insurances are tailored to the needs of the customers, ranging from basic coverage to comprehensive insurance packages. Another important sector of Cigna Corp is the service business. Here, the company offers various services targeting businesses and institutional clients. The service business includes consulting, data analysis, and health programs. The services are designed to support companies in improving the health and well-being of their employees. The services are customized to meet the individual needs of the customers. The third sector of Cigna Corp is the pharmaceutical business. The company is active in this field to provide comprehensive care to its customers. Cigna Corp offers pharmaceutical products that help improve the health and well-being of the customers. The pharmaceutical products of Cigna Corp are tailored to the needs of the customers and recommended by qualified professionals. Another important sector of Cigna Corp is the international business. The company operates in various countries worldwide and offers its products and services internationally. The offerings of Cigna Corp range from international health insurance to health programs and services. The international business of Cigna Corp is tailored to the needs of customers in different countries and is managed by experienced professionals. In summary, Cigna Corp is a company operating in the healthcare industry and offering various products and services. The company operates in different sectors and provides comprehensive care to its customers. The core business of Cigna Corp is health insurance, catering to different needs. The company also offers services to help businesses improve the health and well-being of their employees. Additionally, Cigna Corp operates internationally and offers its products and services in different countries worldwide.
The expected revenue of Cigna Group is 284.84 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of Cigna Group is 8.63 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Cigna Group is currently 8.49. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Cigna Group stock.
The price-to-sales ratio (P/S) of Cigna Group is currently 0.26. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Cigna Group stock.
The Eulerpool Quality Score for Cigna Group is 6/10.
The ISIN of Cigna Group is US1255231003. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Cigna Group is A2PA9L. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Cigna Group is CI. The ticker symbol is used to trade Cigna Group shares on the stock exchange.
Over the past 12 months, Cigna Group paid a dividend of 6.04 USD . This corresponds to a dividend yield of about 2.19 %. For the coming 12 months, Cigna Group is expected to pay a dividend of 7.49 USD.
The current dividend yield of Cigna Group is 2.19 %.
Cigna Group pays a dividend, distributed in the months of , , , .
Cigna Group paid dividends every year for the past 37 years.
For the upcoming 12 months, dividends amounting to 7.49 USD are expected. This corresponds to a dividend yield of 2.68 %.
Cigna Group is assigned to the 'Health' sector.
To receive the latest dividend of Cigna Group from amounting to 1.56 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, Cigna Group distributed 5.6 USD as dividends.
The dividends of Cigna Group are distributed in USD.
Cigna Group stock
Cigna Group Peer Group
Cigna Group Ticker
Cigna Group FIGI
All fundamentals and in-depth analysis of Cigna Group
Our stock analysis for Cigna Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cigna Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.